Post treatment minimal residual disease (MRD) determination contributes to impending relapse prediction, chemotherapy response and clinical outcomes assessment, guiding clinicians to develop reasonable and effective individual chemotherapy options after induction/consolidation. This study was…
Source:Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling
Friday, August 2, 2013
Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment